Literature summary extracted from

Carmona, F.; Lazaro, I.; Reverter, J.C.; Tassies, D.; Font, J.; Cervera, R.; Balasch, J.
Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications (2006), Am. J. Obstet. Gynecol., 194, 457-465.

Application

EC Number	Application	Comment	Organism
3.4.21.38	medicine	impaired factor XIIa-dependent activation of fibrinolysis as a key mechanism related to late-pregnancy complications in patients with the antiphospholipid syndrome	Homo sapiens

Organism

EC Number	Organism	UniProt	Comment	Textmining
3.4.21.38	Homo sapiens	-	patients with antiphospholipid syndrome and late-pregnancy complications	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)